Page 5 - Jay Olson News Today

Operator: Hello, and thank you for standing by. Welcome to Intercept Pharmaceuticals Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.

EXEL earnings call for the period ending June 30, 2023.

Operator: Hello and welcome to the Incyte Second Quarter Earnings Conference Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded.

How creative are you? It's hard to define this in orders, and even harder to measure. But a new test, developed by scientists, aims to measure it once and for all

The summer is now upon us and its sunny days for the markets too. June represented the best month for the S&P 500 since January with the bellwether index delivering gains of 6.5% during the month. The good news, according to Ari Wald, Oppenheimer’s Head of Technical Analysis, is that the rally is set to extend itself further, if history is anything to go by. “We reiterate our expectation for a summertime rally because internal breadth continues to improve, plus the S&P ha...

Biogen Inc. (NASDAQ: BIIB) shares fell Tuesday after it was deemed that the ability of the company's Alzheimer's drug, Leqembi, to slow cognitive decline may not outweigh its risks, according to European experts considering the potential use of it.

City finance officials report that its recent $1.56 billion general obligation bond sale was more than six times oversubcribed.

Olson, a 20-year municipal bond veteran, replaces Marjorie Henning who retired at the end of April. In his new position, he will be in charge of the Bureau of Public Finance, which manages the city's borrowing for the comptroller.

Pfizer's interest in acquiring Seagen stems from a need to recoup patent cliff revenue losses by replenishing its pipeline, analysts say.

The shortened week kicked off with one big crisis averted for now. During the long weekend, an agreement was reached between President Bide...